| Niraparib in patients with newly diagnosed advanced ovarian cancer A González-Martín, B Pothuri, I Vergote, R DePont Christensen, ... New England Journal of Medicine 381 (25), 2391-2402, 2019 | 1702 | 2019 |
| Peritoneal metastases: detection with spiral CT in patients with ovarian cancer FV Coakley, PH Choi, CA Gougoutas, B Pothuri, E Venkatraman, D Chi, ... Radiology 223 (2), 495-499, 2002 | 435 | 2002 |
| Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression L Scotto, G Narayan, SV Nandula, H Arias‐Pulido, S Subramaniyam, ... Genes, Chromosomes and Cancer 47 (9), 755-765, 2008 | 412 | 2008 |
| Promoter Hypermethylation of FANCF Disruption of Fanconi Anemia-BRCA Pathway in Cervical Cancer G Narayan, H Arias-Pulido, SV Nandula, K Basso, DD Sugirtharaj, ... Cancer research 64 (9), 2994-2997, 2004 | 243 | 2004 |
| Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes G Narayan, V Bourdon, S Chaganti, H Arias‐Pulido, SV Nandula, PH Rao, ... Genes, Chromosomes and Cancer 46 (4), 373-384, 2007 | 233 | 2007 |
| Dostarlimab for primary advanced or recurrent endometrial cancer MR Mirza, DM Chase, BM Slomovitz, R dePont Christensen, Z Novák, ... New England Journal of Medicine 388 (23), 2145-2158, 2023 | 211 | 2023 |
| Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression G Narayan, C Goparaju, H Arias-Pulido, AM Kaufmann, A Schneider, ... Molecular cancer 5, 1-10, 2006 | 206 | 2006 |
| Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient … A Oaknin, L Gilbert, AV Tinker, J Brown, C Mathews, J Press, R Sabatier, ... Journal for immunotherapy of cancer 10 (1), 2022 | 194 | 2022 |
| Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer Q Gao, Z Yang, S Xu, X Li, X Yang, P Jin, Y Liu, X Zhou, T Zhang, C Gong, ... Journal of Experimental Medicine 216 (3), 688-703, 2019 | 173 | 2019 |
| Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma B Pothuri, M Montemarano, M Gerardi, M Shike, L Ben-Porat, P Sabbatini, ... Gynecologic oncology 96 (2), 330-334, 2005 | 152 | 2005 |
| Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha L Scotto, G Narayan, SV Nandula, S Subramaniyam, AM Kaufmann, ... Molecular cancer 7, 1-10, 2008 | 144 | 2008 |
| Ovarian cancer: a focus on management of recurrent disease TJ Herzog, B Pothuri Nature clinical practice Oncology 3 (11), 604-611, 2006 | 144 | 2006 |
| Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature MK Frey, B Pothuri Gynecologic oncology research and practice 4, 1-11, 2017 | 139 | 2017 |
| Genetic analysis of the early natural history of epithelial ovarian carcinoma B Pothuri, MM Leitao, DA Levine, A Viale, AB Olshen, C Arroyo, ... PloS one 5 (4), e10358, 2010 | 133 | 2010 |
| Palliative surgery for bowel obstruction in recurrent ovarian cancer: an updated series B Pothuri, A Vaidya, C Aghajanian, E Venkatraman, RR Barakat, DS Chi Gynecologic oncology 89 (2), 306-313, 2003 | 120 | 2003 |
| Brachytherapy: a critical component of primary radiation therapy for cervical cancer: from the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS) CH Holschneider, DG Petereit, C Chu, IC Hsu, YJ Ioffe, AH Klopp, ... Brachytherapy 18 (2), 123-132, 2019 | 112 | 2019 |
| Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper LM Randall, B Pothuri, EM Swisher, JP Diaz, A Buchanan, CT Witkop, ... Gynecologic oncology 146 (2), 217-224, 2017 | 103 | 2017 |
| Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer G Narayan, L Scotto, V Neelakantan, SH Kottoor, AHY Wong, SL Loke, ... Genes, Chromosomes and Cancer 48 (11), 983-992, 2009 | 87 | 2009 |
| Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations CA Hamilton, B Pothuri, RC Arend, FJ Backes, PA Gehrig, PT Soliman, ... Gynecologic oncology 160 (3), 817-826, 2021 | 86* | 2021 |
| BRCA1-and BRCA2-related mutations: therapeutic implications in ovarian cancer B Pothuri Annals of oncology 24, viii22-viii27, 2013 | 69 | 2013 |
